Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
USA117th CongressHRES-280| House
| Updated: 3/29/2021
Ronny Jackson
Republican Representative
Texas
Cosponsors (14)
Diana Harshbarger (Republican)Chip Roy (Republican)Yvette Herrell (Republican)John R. Carter (Republican)Jim Banks (Republican)Scott Franklin (Republican)Victoria Spartz (Republican)Claudia Tenney (Republican)Tom McClintock (Republican)Maria Elvira Salazar (Republican)Jody B. Hice (Republican)James R. Baird (Republican)Brian J. Mast (Republican)John H. Rutherford (Republican)
Ways and Means Committee, Foreign Affairs Committee, Trade Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This resolution commits to the use of competitive free market and free trade policies to combat national security threats caused by China and its attacks on the U.S. pharmaceutical manufacturing base. The resolution urges the United States to (1) remove tax, regulatory, and debt burdens and barriers that have weakened this base; (2) empower the U.S. Trade Representative to take specified actions to counter harmful and unfair trade practices by China; (3) address shortcomings in Food and Drug Administration data collection related to foreign-sourced pharmaceutical ingredients; and (4) identify and streamline regulatory hurdles that have impeded the U.S. pharmaceutical manufacturing base.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Trade.
Referred to the Subcommittee on Health.
Foreign Trade and International Finance
Administrative law and regulatory proceduresAsiaChinaCompetition and antitrustCompetitiveness, trade promotion, trade deficitsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Free trade and trade barriersGovernment information and archivesHealth technology, devices, suppliesManufacturingPrescription drugsTrade agreements and negotiations
Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.
USA117th CongressHRES-280| House
| Updated: 3/29/2021
This resolution commits to the use of competitive free market and free trade policies to combat national security threats caused by China and its attacks on the U.S. pharmaceutical manufacturing base. The resolution urges the United States to (1) remove tax, regulatory, and debt burdens and barriers that have weakened this base; (2) empower the U.S. Trade Representative to take specified actions to counter harmful and unfair trade practices by China; (3) address shortcomings in Food and Drug Administration data collection related to foreign-sourced pharmaceutical ingredients; and (4) identify and streamline regulatory hurdles that have impeded the U.S. pharmaceutical manufacturing base.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committees on Foreign Affairs, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Trade.
Referred to the Subcommittee on Health.
Ronny Jackson
Republican Representative
Texas
Cosponsors (14)
Diana Harshbarger (Republican)Chip Roy (Republican)Yvette Herrell (Republican)John R. Carter (Republican)Jim Banks (Republican)Scott Franklin (Republican)Victoria Spartz (Republican)Claudia Tenney (Republican)Tom McClintock (Republican)Maria Elvira Salazar (Republican)Jody B. Hice (Republican)James R. Baird (Republican)Brian J. Mast (Republican)John H. Rutherford (Republican)
Ways and Means Committee, Foreign Affairs Committee, Trade Subcommittee, Health Subcommittee, Energy and Commerce Committee
Foreign Trade and International Finance
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresAsiaChinaCompetition and antitrustCompetitiveness, trade promotion, trade deficitsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Free trade and trade barriersGovernment information and archivesHealth technology, devices, suppliesManufacturingPrescription drugsTrade agreements and negotiations